Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog
L R Fitzpatrick, R M Lambert, C E Pendley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2021
Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists
George Tora, Ji Jiang, Jeffrey S Bostwick, et al.
Journal of Medicinal Chemistry
|
July 3, 1998
Design of a new class of orally active fibrinogen receptor antagonists
S I Klein, B F Molino, M Czekaj, et al.
Journal of Medicinal Chemistry
|
December 2, 2021
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure
Wei Meng, Zulan Pi, Robert Brigance, et al.
Journal of Cardiovascular Pharmacology
|
December 22, 1999
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor Xa
R J Leadley, S R Morgan, R Bentley, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Identification of 6-Hydroxypyrimidin-4(1<i>H</i>)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists
Zulan Pi, James A Johnson, Wei Meng, et al.
Journal of Medicinal Chemistry
|
March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate
James A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility
Tammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Chemmedchem
|
July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution
Jennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1990
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog
L R Fitzpatrick, R M Lambert, C E Pendley, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 17, 2021
Identification of 6-hydroxy-5-phenyl sulfonylpyrimidin-4(1H)-one APJ receptor agonists
George Tora, Ji Jiang, Jeffrey S Bostwick, et al.
Journal of Medicinal Chemistry
|
July 3, 1998
Design of a new class of orally active fibrinogen receptor antagonists
S I Klein, B F Molino, M Czekaj, et al.
Journal of Medicinal Chemistry
|
December 2, 2021
Identification of a Hydroxypyrimidinone Compound (<b>21</b>) as a Potent APJ Receptor Agonist for the Potential Treatment of Heart Failure
Wei Meng, Zulan Pi, Robert Brigance, et al.
Journal of Cardiovascular Pharmacology
|
December 22, 1999
Pharmacodynamic activity and antithrombotic efficacy of RPR120844, a novel inhibitor of coagulation factor Xa
R J Leadley, S R Morgan, R Bentley, et al.
ACS Medicinal Chemistry Letters
|
November 19, 2021
Identification of 6-Hydroxypyrimidin-4(1<i>H</i>)-one-3-carboxamides as Potent and Orally Active APJ Receptor Agonists
Zulan Pi, James A Johnson, Wei Meng, et al.
Journal of Medicinal Chemistry
|
March 10, 2021
Discovery of a Hydroxypyridinone APJ Receptor Agonist as a Clinical Candidate
James A Johnson, Soong-Hoon Kim, Ji Jiang, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2013
Discovery of diarylurea P2Y(1) antagonists with improved aqueous solubility
Tammy C Wang, Jennifer X Qiao, Charles G Clark, et al.
Journal of Medicinal Chemistry
|
February 22, 2024
Discovery of Potent and Selective Quinoxaline-Based Protease-Activated Receptor 4 (PAR4) Antagonists for the Prevention of Arterial Thrombosis
Xiaojun Zhang, Wen Jiang, Jeremy M Richter, et al.
Chemmedchem
|
July 4, 2014
4-Benzothiazole-7-hydroxyindolinyl diaryl ureas are potent P2Y1 antagonists with favorable pharmacokinetics: low clearance and small volume of distribution
Jennifer X Qiao, Tammy C Wang, Sheldon Hiebert, et al.
Page
of 4